Skip to content

Johnson & Johnson JNJ Indefinite-Lived Intangible Assets

Discontinued — last reported Q3 '14

Indefinite-Lived Intangible Assets at other companies

AbbVie logo
AbbVieABBV
$5.27B-0.4%
Abbott logo
AbbottABT
Tenet Healthcare logo
Tenet HealthcareTHC
Pfizer logo
PfizerPFE
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Boston Scientific logo
Boston ScientificBSX

Segments

By segment

See full
MedTech$1.7B

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$623.71B+66.9%
Enterprise value$657.01B+61.9%
P/E29.6×+13.2×
P/S6.5×+2.3×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Johnson & Johnson’s 10-Q, filed October 30, 2014, on SEC EDGAR. View the filing →

Questions, answered.

What does indefinite-lived intangible assets mean?
This represents intangible assets, such as iconic brand names or trademarks, that are expected to generate cash flows for an unlimited period. Unlike finite-lived assets, these are not amortized but are tested annually for impairment. They represent the core long-term value of the company's brand portfolio.